Ketorolac (30 mg) Injection | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Ketorolac (30 mg) Injection
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Injection
Class: Oral NSAID (Short-term)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Ketorolac (30 mg) Injection Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Ketorolac (30 mg) Injection brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Ketorolac (30 mg) Injection is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Ketorolac (30 mg) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Step-down after IV Ketorolac
- Acute moderate-severe musculoskeletal pain
- Post-extraction dental pain
- Acute migraine (rescue)
Mechanism of Action
Ketorolac is a potent non-selective NSAID with primarily analgesic action (similar to opioid efficacy for short-term acute pain). Inhibits COX-1/COX-2 reducing prostaglandin synthesis. Restricted to ≤5 days use due to high GI/renal toxicity vs other NSAIDs.
Dosage & Administration
- Adults: 10 mg every 4–6 hours.
- Maximum 5 days (combined IV+oral).
- Maximum 40 mg/day.
Side Effects
- GI upset, ulceration, AKI risk, hypertension.
- Higher GI toxicity than other oral NSAIDs.
Contraindications
- Active peptic ulcer, severe renal impairment, asthma (NSAID-induced), pregnancy, breastfeeding.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Ketorolac (30 mg) Injection
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 1ml (Tray Pack)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Ketorolac (30 mg) Injection — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Ketorolac (30 mg) Injection, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Ketorolac (30 mg) Injection?
Trumac Healthcare is a WHO-GMP certified manufacturer of Ketorolac (30 mg) Injection in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Ketorolac (30 mg) Injection available for PCD pharma franchise on monopoly basis?
Yes. We offer Ketorolac (30 mg) Injection for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Ketorolac (30 mg) Injection?
Available pack sizes include: 10 x 1ml (Tray Pack).
What is the MRP / trade price for Ketorolac (30 mg) Injection?
MRPs range from ₹31 to ₹31 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Ketorolac (30 mg) Injection?